MRI-based thrombolytic therapy in patients with acute ischemic stroke presenting with a low NIHSS.

Shahram MajidiMarie LubyJohn K LynchAmie W HsiaRichard T BensonChandni P KalariaZurab NadareishviliLawrence L LatourRichard Leigh

Published in: Neurology (2019)

This study provides Class IV evidence that for patients with acute ischemic stroke and NIHSS ≤5 screened with MRI, IV tissue plasminogen activator is safe.

Keyphrases

acute ischemic stroke
contrast enhanced
magnetic resonance imaging
diffusion weighted imaging
case report
smoking cessation